Cleaning and Sterilization in Place Systems segmentation by application illustrates how end‑user requirements shape market dynamics. The pharmaceutical segment remains the dominant driver, representing roughly 45 % of revenue, because strict GMP regulations compel continuous CIP/SIP cycles for reactors, fermenters, and isolators. Food & beverage accounts for an estimated 30 % share, reflecting the sector’s need to comply with HACCP standards and to mitigate cross‑contamination in dairy, beverage, and processed‑food lines. Biotechnology, encompassing cell‑culture and biologics production, contributes about 15 % as the industry adopts closed‑system architectures that rely heavily on automated CIP/SIP solutions. Water‑treatment installations, primarily for reverse‑osmosis and membrane‑based plants, generate approximately 7 % of the market, driven by the necessity to prevent bio‑fouling and scale formation. The cosmetics segment, though niche, adds roughly 3 % as manufacturers implement CIP/SIP to meet stringent purity and allergen‑free specifications. Each application segment’s share directly translates into equipment volume, service contracts, and aftermarket demand, cumulatively defining the market’s size and growth trajectory.